Skip to main navigation
Skip to search
Skip to main content
Sort by
Nursing and Health Professions
Construct Validity
100%
Tacrolimus
100%
Eculizumab
100%
Pirfenidone
100%
Nintedanib
100%
Internal Consistency
50%
Cronbach Alpha Coefficient
50%
Side Effect
50%
Test Retest Reliability
50%
Confirmatory Factor Analysis
50%
Discriminant Validity
50%
Kidney Transplantation
50%
Convergent Validity
50%
Patient-Reported Outcome
50%
Fibrosing Alveolitis
50%
Hemolytic Uremic Syndrome
50%
Keyphrases
Patient Satisfaction
100%
Patient Experience
100%
Satisfaction with Medication
100%
Generic Modules
55%
Netherlands
22%
Construct Validity
22%
Tacrolimus
22%
Nintedanib
22%
Eculizumab
22%
Pirfenidone
22%
Confirmatory Factor Analysis
11%
Medication Use
11%
Cronbach's alpha
11%
Structural Properties
11%
Internal Consistency
11%
Discriminant Validity
11%
Test-retest Reliability
11%
Intraclass Correlation Coefficient
11%
Convergent Validity
11%
Daily Life
11%
Patient Perspective
11%
Idiopathic Pulmonary Fibrosis
11%
Patient-Reported Outcomes Measurement Information System (PROMIS)
11%
Kidney Transplantation
11%
Recommendation Method
11%
Consistency Value
11%
Atypical Hemolytic Uremic Syndrome (aHUS)
11%
Scoring Algorithm
11%
Construct Reliability
11%
Medicine and Dentistry
Patient Experience
100%
Tacrolimus
22%
Nintedanib
22%
Eculizumab
22%
Pirfenidone
22%
Idiopathic Pulmonary Fibrosis
11%
Side Effect
11%
Kidney Transplantation
11%
Confirmatory Factor Analysis
11%
Test Retest Reliability
11%
Patient-Reported Outcome
11%
Atypical Hemolytic Uremic Syndrome
11%
INIS
patients
100%
reliability
22%
netherlands
11%
algorithms
5%
values
5%
side effects
5%
kidneys
5%
fibrosis
5%